Effect of Alveolar Minute Ventilation on Respiratory Gas Heat Content

Sponsor
University of California, Davis (Other)
Overall Status
Completed
CT.gov ID
NCT01943227
Collaborator
(none)
20
1
7
2.9

Study Details

Study Description

Brief Summary

This is a single site, prospective, non-blinded, non-randomized, non-interventional study designed to evaluate the effect of changes in alveolar minute ventilation on the measurement of respiratory heat loss (enthalpy).

Condition or Disease Intervention/Treatment Phase
  • Other: controlled positive pressure ventilation 9ml/kg tidal volume
  • Other: controlled positive pressure ventilation 6ml/kg tidal volume

Detailed Description

This is a single site, prospective, non-blinded, non-randomized, noninterventional study designed to evaluate the effect of changes in alveolar minute ventilation on the measurement of respiratory heat loss (enthalpy). Each patient will serve as their own control. The study will enroll adult patients without cardiac or respiratory illness. It is designed to evaluate the effect of the ventilatory pattern (tidal volume, rate) on respiratory heat loss measured using the VQm™ monitor during standard intra-operative clinical care that requires positive pressure ventilation (PPV)

Study Design

Study Type:
Observational
Actual Enrollment :
20 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Effect of Alveolar Minute Ventilation on Respiratory Gas Heat Content
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
Mar 1, 2014
Actual Study Completion Date :
Mar 1, 2014

Arms and Interventions

Arm Intervention/Treatment
6ml/kg

Enthalpy measured in patients receiving controlled positive pressure ventilation 6ml/kg Tidal volume. The VQm monitor samples the gas at a rate of 3 L/min, returning the analyzed gas to the circuit. As the exhaled gas passes through the analytical chamber, the temperature and humidity are measured essentially continuously (40Hz). These data are combined with pressure measurements to determine the exhaled gas volume and then the heat content (enthalpy) is calculated.

Other: controlled positive pressure ventilation 6ml/kg tidal volume
controlled positive pressure ventilation 6ml/kg tidal volume

9ml/kg

Enthalpy measured in patients receiving controlled positive pressure ventilation 9ml/kg Tidal volume. The VQm monitor samples the gas at a rate of 3 L/min, returning the analyzed gas to the circuit. As the exhaled gas passes through the analytical chamber, the temperature and humidity are measured essentially continuously (40Hz). These data are combined with pressure measurements to determine the exhaled gas volume and then the heat content (enthalpy) is calculated.

Other: controlled positive pressure ventilation 9ml/kg tidal volume
controlled positive pressure ventilation 9ml/kg tidal volume

Outcome Measures

Primary Outcome Measures

  1. Airway Enthalpy [12 months]

    This is a single site, prospective, non-blinded, non-randomized, non-interventional study designed to evaluate the effect of changes in alveolar minute ventilation on the measurement of respiratory heat loss (enthalpy) in Joules per minute.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age greater than 18 years

  • scheduled for an elective surgical procedure with an anticipated duration of more than 2 hours requiring general anesthesia and positive pressure ventilation using an endotracheal tube

  • patient status ASA 1, 2 or 3

  • no significant cardio-vascular or respiratory disease

  • supine surgical position

Exclusion Criteria:
  • Adults unable to give primary consent

  • age less than 18 years

  • pregnancy

  • prisoners

  • pre-existing cardiac or pulmonary disease

  • infusion of inotropic drugs

  • positive end expiratory pressure (PEEP) requirements >8 cm H2O

  • increased intra-abdominal pressure (e.g. planned surgical pneumoperitoneum or ascitis)

  • intra-operative patient position other than supine

Contacts and Locations

Locations

Site City State Country Postal Code
1 UC Davis Health System Sacramento California United States 95817

Sponsors and Collaborators

  • University of California, Davis

Investigators

  • Principal Investigator: Neal Fleming, MD, PhD, Professor, Anesthesiology & Pain Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01943227
Other Study ID Numbers:
  • 483184
First Posted:
Sep 16, 2013
Last Update Posted:
Oct 28, 2019
Last Verified:
Oct 1, 2019
Keywords provided by University of California, Davis

Study Results

Participant Flow

Recruitment Details Patient recruitment and informed consent will be obtained in the UCDMC perioperative suite. Recruitment will be by direct discussion between the prospective candidates and the study investigators prior to their scheduled surgical procedure. The investigators will provide the consent form in person and give subject time to discuss with family.
Pre-assignment Detail The screening of patients will require the investigators to access personal health information to identify prospective subjects without HIPAA authorization. The research could not be practicably carried out without this waiver of consent. The risk of harm from contacting the participants is greater than the risk of the study procedures.
Arm/Group Title Large Tidal Volume Smal Tidal Volume
Arm/Group Description Change in airway heat content Change in airway heat content
Period Title: Overall Study
STARTED 10 10
COMPLETED 10 10
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Large Tidal Volume Small Tidal Volume Total
Arm/Group Description Airway heat content Airway heat content Total of all reporting groups
Overall Participants 10 10 20
Age (Count of Participants)
<=18 years
0
0%
0
0%
0
0%
Between 18 and 65 years
10
100%
10
100%
20
100%
>=65 years
0
0%
0
0%
0
0%
Age (Years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Years]
44
(10.8)
42
(13.8)
43
(12.5)
Sex: Female, Male (Count of Participants)
Female
6
60%
3
30%
9
45%
Male
4
40%
7
70%
11
55%
Region of Enrollment (participants) [Number]
United States
10
100%
10
100%
20
100%

Outcome Measures

1. Primary Outcome
Title Airway Enthalpy
Description This is a single site, prospective, non-blinded, non-randomized, non-interventional study designed to evaluate the effect of changes in alveolar minute ventilation on the measurement of respiratory heat loss (enthalpy) in Joules per minute.
Time Frame 12 months

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Large Tidal Volume Smal Tidal Volume
Arm/Group Description Change in airway heat content Change in airway heat content
Measure Participants 10 10
Mean (Standard Deviation) [Joules/Minute]
32
(9.1)
23
(8.9)

Adverse Events

Time Frame 24 hours
Adverse Event Reporting Description
Arm/Group Title Large Tidal Volume Small Tidal Volume
Arm/Group Description Airway heat content Airway heat content
All Cause Mortality
Large Tidal Volume Small Tidal Volume
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/10 (0%) 0/10 (0%)
Serious Adverse Events
Large Tidal Volume Small Tidal Volume
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/10 (0%) 0/10 (0%)
Other (Not Including Serious) Adverse Events
Large Tidal Volume Small Tidal Volume
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/10 (0%) 0/10 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Neal Fleming, MD, PhD
Organization UC Davis Medical Center
Phone 916-734-5046
Email nwfleming@ucdavis.edu
Responsible Party:
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01943227
Other Study ID Numbers:
  • 483184
First Posted:
Sep 16, 2013
Last Update Posted:
Oct 28, 2019
Last Verified:
Oct 1, 2019